FDA move will not hit vaccination policy: Govt

Bharat Biotech International’s application for emergency use authorization (EUA) of Covaxin before the US Food and Drug Administration (USFDA) was rejected due to lack of sufficient data on the covid-19 vaccine’s safety and efficacy

from mint - News https://ift.tt/3iBeMgs
https://ift.tt/eA8V8J